J S March
Overview
Explore the profile of J S March including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
2528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
March J, Vitiello B
Clin Pharmacol Ther
. 2009 Sep;
86(4):355-7.
PMID: 19763113
No abstract available.
2.
March J, Johnston H, Jefferson J, Kobak K, Greist J
J Child Adolesc Psychopharmacol
. 2009 Jul;
1(2):133-40.
PMID: 19630661
ABSTRACT A 10-week double-blind, placebo-controlled design was employed to investigate the effectiveness of clomipramine (CMI) versus placebo in 16 outpatients (ages 10-18 years) with obsessive-compulsive disorder (OCD). While a trend...
3.
Johnston H, Swift W, March J
J Child Adolesc Psychopharmacol
. 2009 Jul;
3(2):115-25.
PMID: 19630642
ABSTRACT It is well known that some adults with major depression fail to respond to tricyclic antidepressants (TCA) at typical doses and plasma levels, but do respond at higher than...
4.
Waters T, Barrett P, March J
Am J Psychother
. 2001 Oct;
55(3):372-87.
PMID: 11641879
The effectiveness of a 14-week cognitive-behavioral family treatment protocol for childhood obsessive-compulsive disorder (OCD) was piloted using a volunteer sample of seven children aged 10-14 years. The primary outcome measures...
5.
Cook E, Wagner K, March J, Biederman J, Landau P, Wolkow R, et al.
J Am Acad Child Adolesc Psychiatry
. 2001 Oct;
40(10):1175-81.
PMID: 11589530
Objective: To evaluate the safety and effectiveness of sertraline in the long-term treatment of pediatric obsessive-compulsive disorder (OCD). Method: Children (6-12 years; n= 72) and adolescents (13-18 years; n =...
6.
March J, Vitiello B
Int J Neuropsychopharmacol
. 2001 Jul;
4(2):141-7.
PMID: 11466164
This Special Section of Int J Neuropsychopharmacol highlights current progress in paediatric neuropsychopharmacology. Combining critical reviews and, in some cases, new data, specific topics include: biological findings in major depression,...
7.
Compton S, Grant P, Chrisman A, Gammon P, Brown V, March J
J Am Acad Child Adolesc Psychiatry
. 2001 May;
40(5):564-71.
PMID: 11349701
Objective: The aim of this open-label study was to assess the therapeutic benefits, response pattern, and safety of sertraline in children with social anxiety disorder. Method: Fourteen outpatient subjects with...
8.
March J, Franklin M, Nelson A, Foa E
J Clin Child Psychol
. 2001 Apr;
30(1):8-18.
PMID: 11294080
Discusses the cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder (OCD). Over the past 15 years, cognitive-behavioral psychotherapy has emerged as the psychosocial treatment of choice for OCD across lifespan. Unlike other...
9.
Jensen P, Hinshaw S, Swanson J, Greenhill L, Conners C, Arnold L, et al.
J Dev Behav Pediatr
. 2001 Mar;
22(1):60-73.
PMID: 11265923
In 1992, the National Institute of Mental Health and 6 teams of investigators began a multisite clinical trial, the Multimodal Treatment of Attention-Deficit Hyperactivity Disorder (MTA) study. Five hundred seventy-nine...
10.
Vitiello B, Severe J, Greenhill L, Arnold L, Abikoff H, Bukstein O, et al.
J Am Acad Child Adolesc Psychiatry
. 2001 Feb;
40(2):188-96.
PMID: 11211367
Objectives: To examine the trajectory of methylphenidate (MPH) dosage over time, following a controlled titration, and to ascertain how accurately the titration was able to predict effective long-term treatment in...